PROCHLORPERAZINE EDISYLATE INJECTION, USP 10 mg/2mL (5mg/mL), 2mL Vial, Rx Only, Mfg by: Emcure P...

FDA Drug Recall #D-1397-2019 — Class I — May 21, 2019

Recall Summary

Recall Number D-1397-2019
Classification Class I — Serious risk
Date Initiated May 21, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Heritage Pharmaceuticals, Inc.
Location East Brunswick, NJ
Product Type Drugs
Quantity 55,480 2 mL vials

Product Description

PROCHLORPERAZINE EDISYLATE INJECTION, USP 10 mg/2mL (5mg/mL), 2mL Vial, Rx Only, Mfg by: Emcure Pharmaceuticals Ltd., Hinjawadi, Pune, India. Mfg for: Heritage Pharmaceuticals Inc. NDC 23155-294-31

Reason for Recall

Non-Sterility:Microbial growth detected in sub lot of Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL) .

Distribution Pattern

Nationwide in the USA

Lot / Code Information

Lot: VPCA172, EXP April 2020

Other Recalls from Heritage Pharmaceuticals, Inc.

Recall # Classification Product Date
D-1398-2019 Class I AMIKACIN SULFATE INJECTION, USP, 1 gram/4 mL (2... May 21, 2019
D-1291-2019 Class II Losartan Potassium Tablets USP 25 mg 90 film co... May 3, 2019
D-1289-2019 Class II Losartan Potassium Tablets USP 50 mg 90 film co... May 3, 2019
D-1290-2019 Class II Losartan Potassium Tablets USP 100 mg 1000 film... May 3, 2019
D-1288-2019 Class II Losartan Potassium Tablets USP 100 mg 90 film c... May 3, 2019

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.